Viol Co Ltd
KOSDAQ:335890
Net Margin
Viol Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
KR |
V
|
Viol Co Ltd
KOSDAQ:335890
|
475.2B KRW |
56%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
224.3B USD |
32%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
183.1B USD |
28%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
150.7B USD |
12%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
139.8B USD |
13%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
107.8B USD |
13%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
52.9B EUR |
9%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
59.3B USD |
8%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
44.5B USD |
75%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35.4B USD |
23%
|
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
257.8B CNY |
33%
|
Viol Co Ltd
Glance View
VIOL Co., Ltd. is engaged in the provision of financial support services. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-12-03. The firm's main product is Scarlet, an equipment for elasticity and lifting. In addition, the Company develops and produces medical devices for anti-aging skin care. The firm sells its products in domestic and overseas markets such as China and the United States.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Viol Co Ltd's most recent financial statements, the company has Net Margin of 56.1%.